SCHEMBL497311

SCHEMBL497311

O=C(Nc1ccc(Cl)cc1Cl)c1c(Nc2ccccc2)[nH]c2c(Cl)cc(Cl)cc2c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 6/20 0.51
CTSB P07858 5/20 0.51
CTSL P07711 4/20 0.51
CTSH P09668 2/20 0.51
CTSD P07339 1/20 0.51
LIN28A Q9H9Z2 2/20 0.48
KDM4E B2RXH2 3/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPK10 P53779 1/20 0.42
HTT P42858 2/20 0.42
ATM Q13315 1/20 0.39
ALOX5 P09917 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL497135 0.90 CAPN1 (0.60) CAPN1CTSBCTSLCTSHCTSD
SCHEMBL3326999 0.84 CAPN1 (0.52) CAPN1CTSBCTSLCTSHCTSD
SCHEMBL3324591 0.81 CAPN1 (0.62) CAPN1CTSBCTSLCTSHCTSD
SCHEMBL496522 0.78 CAPN1 (0.46) CAPN1CTSBCTSLCTSHCTSD
SCHEMBL497811 0.76 CAPN1 (0.47) CAPN1CTSBCTSLCTSHCTSD
SCHEMBL8804658 0.67 KDM4E (0.82) KDM4ENPSR1RXFP1NPC1RAB9A
SCHEMBL20094709 0.65 CAPN1 (0.56) CAPN1CTSBCTSLCTSHCTSD
SCHEMBL24186183 0.65 CAPN1 (0.59) CAPN1CTSBCTSLCTSHCTSD
SCHEMBL30668243 0.65 CAPN1 (0.59) CAPN1CTSBCTSLCTSHCTSD
SCHEMBL30668241 0.65 CAPN1 (0.59) CAPN1CTSBCTSLCTSHCTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106071-B2 Compositions for treating hyperproliferative vascular disorders and cancers BIOBUD CO., LTD. (KR) 2012-01-31 US disclosed